Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04091672 · ClinicalTrials.gov registry record · NA
RECELL® System Combined With Meshed Autograft for Reduction of Donor Skin Harvesting in Soft Tissue Reconstruction
A NA study, sponsored by Avita Medical.
- Completed
- Registry status
- NA
- Development phase
- 65
- Enrollment target
NCT04091672 is a NA study that has completed, run by Avita Medical. The registered enrollment target is 65 participants.
The verdict
NCT04091672, a NA study, has completed, sponsored by Avita Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
Study Summary
A prospective randomized within-subject controlled study to compare the clinical performance of conventional autografting with and without the RECELL system on acute non-burn full-thickness skin defects.
Interventions
- PROCEDURE Control Intervention (Conventional Autograft)
- DEVICE Investigational Intervention (RECELL + more widely meshed autograft)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2020-03-02 |
| Est. Completion | 2023-02-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04091672
The ClinicalTrials.gov registry entry for NCT04091672 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Avita Medical, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control Intervention (Conventional Autograft) is the first listed.
NCT04091672 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04091672 about?
NCT04091672 is a clinical study titled "RECELL® System Combined With Meshed Autograft for Reduction of Donor Skin Harvesting in Soft Tissue Reconstruction". A prospective randomized within-subject controlled study to compare the clinical performance of conventional autografting with and without the RECELL system on acute non-burn full-thickness skin defects.
What is the current status of trial NCT04091672?
This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2020-03-02. Estimated completion is 2023-02-02.
What interventions are being tested in trial NCT04091672?
The interventions under investigation include: Control Intervention (Conventional Autograft) (PROCEDURE), Investigational Intervention (RECELL + more widely meshed autograft) (DEVICE).
Who is sponsoring clinical trial NCT04091672?
This trial is sponsored by Avita Medical, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.